These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8386897)

  • 21. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.
    Mendell JR; Sahenk Z; Gales T; Paul L
    Arch Neurol; 1991 Dec; 48(12):1229-34. PubMed ID: 1668977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
    Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
    Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles].
    Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G
    Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis.
    Askanas V; Engel WK; Alvarez RB; Glenner GG
    Lancet; 1992 Feb; 339(8792):560-1. PubMed ID: 1346915
    [No Abstract]   [Full Text] [Related]  

  • 25. Fast and reliable new method for electron-microscopic identification of cytoplasmic tubulo-filaments in muscle biopsies of patients with inclusion-body myositis.
    Askanas V; Alvarez RB
    Acta Neuropathol; 1992; 84(3):335-6. PubMed ID: 1329431
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
    Sarkozi E; Askanas V; Engel WK
    Am J Pathol; 1994 Dec; 145(6):1280-4. PubMed ID: 7992832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle.
    Jaworska-Wilczynska M; Wilczynski GM; Engel WK; Strickland DK; Weisgraber KH; Askanas V
    Neurology; 2002 Feb; 58(3):438-45. PubMed ID: 11839845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BACE1 and BACE2 in pathologic and normal human muscle.
    Vattemi G; Engel WK; McFerrin J; Pastorino L; Buxbaum JD; Askanas V
    Exp Neurol; 2003 Feb; 179(2):150-8. PubMed ID: 12618121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
    Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
    Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein.
    Broccolini A; Engel WK; Alvarez RB; Askanas V
    Am J Pathol; 2000 Apr; 156(4):1151-5. PubMed ID: 10751338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial inclusion body myositis among Kurdish-Iranian Jews.
    Massa R; Weller B; Karpati G; Shoubridge E; Carpenter S
    Arch Neurol; 1991 May; 48(5):519-22. PubMed ID: 1850594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative morphometric study of muscle in inclusion body myositis.
    Verma A; Bradley WG; Soule NW; Pendlebury WW; Kelly J; Adelman LS; Chou SM; Karpati G; Brenner JF
    J Neurol Sci; 1992 Oct; 112(1-2):192-8. PubMed ID: 1335036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitin expression in inclusion body myositis. An immunohistochemical study.
    Albrecht S; Bilbao JM
    Arch Pathol Lab Med; 1993 Aug; 117(8):789-93. PubMed ID: 8393651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion body myositis with abundant ring fibers.
    Del Bigio MR; Jay V
    Acta Neuropathol; 1992; 85(1):105-10. PubMed ID: 1337419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redox factor-1 in muscle biopsies of patients with inclusion-body myositis.
    Broccolini A; Engel WK; Alvarez RB; Askanas V
    Neurosci Lett; 2000 Jun; 287(1):1-4. PubMed ID: 10841976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.
    Jin LW; Hearn MG; Ogburn CE; Dang N; Nochlin D; Ladiges WC; Martin GM
    Am J Pathol; 1998 Dec; 153(6):1679-86. PubMed ID: 9846957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation.
    Wilczynski GM; Engel WK; Askanas V
    Am J Pathol; 2000 Jun; 156(6):1835-40. PubMed ID: 10854206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion body myositis: explanation for poor response to immunosuppressive therapy.
    Barohn RJ; Amato AA; Sahenk Z; Kissel JT; Mendell JR
    Neurology; 1995 Jul; 45(7):1302-4. PubMed ID: 7617187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele.
    Askanas V; Engel WK; Alvarez RB; Frangione B; Ghiso J; Vidal R
    Ann Neurol; 2000 Apr; 47(4):544-9. PubMed ID: 10762172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inclusion body myositis and Welander distal myopathy: a clinical, neurophysiological and morphological comparison.
    Lindberg C; Borg K; Edström L; Hedström A; Oldfors A
    J Neurol Sci; 1991 May; 103(1):76-81. PubMed ID: 1650819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.